Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Debt / NOTE 1.500%10/1
-
Market price (% of par)
-
117.69%
-
Total 13F principal
-
$339,236,012
-
Principal change
-
+$24,849,000
-
Total reported market value
-
$399,582,215
-
Number of holders
-
39
-
Value change
-
+$28,890,823
-
Number of buys
-
17
-
Number of sells
-
19
Institutional Holders of BIOMARIN PHARMACEUTICAL INC - NOTE 1.500%10/1 as of Q4 2016
As of 31 Dec 2016,
BIOMARIN PHARMACEUTICAL INC - NOTE 1.500%10/1 was held by
39 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$339,236,012
in principal (par value) of the bond.
The largest 10 bondholders included
Linden Advisors LP, Invesco Ltd., FRANKLIN RESOURCES INC, ADVENT CAPITAL MANAGEMENT /DE/, SHENKMAN CAPITAL MANAGEMENT INC, FMR LLC, Calamos Advisors LLC, ROYAL BANK OF CANADA, LAZARD ASSET MANAGEMENT LLC, and BANK OF AMERICA CORP /DE/.
This page lists
39
institutional bondholders reporting positions
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.